Download
1 / 4
40 likes | 47 Views
Asia-Pacific metered dose inhaler market is anticipated to grow at a substantial rate of around 4.5% during the forecast period. Major factors that augment the growth of the market include a large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and the significant presence of market players in the region. Asia-Pacific has a potential market due to the increasing R&D and investments by big pharmaceutical companies in life science research coupled with harnessing innovation.
E N D
Orion Market Research Asia-Pacific Metered Dose Inhaler Market:Industry Growth, Size, Share and Forecast 2019-2025 Request https://www.omrglobal.com/request-sample/asia-pacific-metered-dose-inhaler-market -------------------------------------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040 a Free Sample of Report Asia-Pacific Metered Dose Inhaler Market at
Asia-Pacific metered dose inhaler market is anticipated to grow at a substantial rate of around 4.5% during the forecast period. Major factors that augment the growth of the market include a large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and the significant presence of market players in the region. Asia-Pacific has a potential market due to the increasing R&D and investments by big pharmaceutical companies in life science research coupled with harnessing innovation. The metered dose inhaler market in the Asia-Pacific region promises future opportunities for growth as the prevalence of respiratory diseases such as asthma, COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growth of the market. A full Report of Asia-Pacific Metered Dose Inhaler Market at https://www.omrglobal.com/industry- reports/asia-pacific-metered-dose-inhaler-market Asia-Pacific metered dose inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhalers are analyzed. The preventive inhaler segment led the global metered dose inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/asia-pacific-metered-dose-inhaler-market Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing metered dose inhalers to cater to a wide range of customers within the region and across the globe. The major players of the Asia-Pacific metered dose inhaler market include 3M Co., AstraZeneca PLC, Aradigm Corp., Adherium Ltd., GlaxoSmithKline PLC, Novartis AG, Propeller Health, Teva Pharmaceuticals Industries Ltd. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. For instance, in May 2018, the company established a partnership with MannKind for marketing and distributing Afrezza. It is the only US FDA approved inhaled insulin available for patients suffering from diabetes. In addition, the company in February 2018, has entered into a partnership with Roche Pharma India for healthcare improvement and increasing access to life-changing medicines in India.
Asia-Pacific Metered Dose Inhaler Market Segmentation By Device Type •Preventive Inhaler •Reliever Inhaler •Long Acting Bronchodilators Inhaler By Application •Asthma •Chronic Obstructive Pulmonary Disease (COPD) By End-User •Homecare •Hospitals and Clinics Regional Analysis •China •Japan •India •Rest of Asia-Pacific Company Profiles •3M Co. •Acorda Therapeutics, Inc. •Adamis Pharmaceuticals Corp. •Adherium Ltd. •Aradigm Corp. •AstraZeneca PLC •Beximo Pharmaceuticals Ltd. •Boehringer Ingelheim International GmbH •Cipla Ltd. •GlaxoSmithKline PLC •Koninklijke Philips N.V. •MidasCare Pharmaceutical Pvt. Ltd. •Novartis AG •Omron Healthcare Inc.
•ResMed Corp. •Sunovion Pharmaceuticals •Teijin Pharma Ltd. •Teva Pharmaceuticals Industries Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/asia-pacific-metered-dose-inhaler-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. AnuragTiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404
